Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2008 08:00 ET | Source: Eurand N.V.

Eurand Reports First Quarter 2008 Key Achievements and Financial Results

Highlights: * EUR-1008 (Zentase(r)) NDA accepted and granted priority review status by FDA * EUR-1008 (Zentase(r)) MAA received eligibility for centralized review procedure in European...
April 30, 2008 09:00 ET | Source: Eurand N.V.

Eurand to Present At Upcoming Conferences

AMSTERDAM, Netherlands, April 30, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
April 29, 2008 09:43 ET | Source: Eurand N.V.

Eurand Announces Launch of OTC Unisom SleepMelts by Chattem

MILAN, Italy and DAYTON, Ohio, April 29, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical...
April 22, 2008 09:00 ET | Source: Eurand N.V.

Eurand Announces EUR-1008 (Zentase) Eligibility for European Centralized Review

MILAN, Italy, April 22, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
April 17, 2008 09:00 ET | Source: Eurand N.V.

Eurand Announces First Quarter 2008 Financial Results Conference Call

AMSTERDAM, Netherlands, April 17, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
April 15, 2008 09:00 ET | Source: Eurand N.V.

Eurand in Licenses Corticosteroid GI Product From Chiesi Farmaceutici SpA

PHILADELPHIA, April 15, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
April 09, 2008 17:38 ET | Source: Eurand N.V.

Eurand Receives a Notice of Allowance for U.S. Patent Application Covering Amrix

DAYTON, Ohio, April 9, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
March 10, 2008 09:00 ET | Source: Eurand N.V.

Eurand to Present At the Lehman Brothers 11th Annual Global Healthcare Conference

AMSTERDAM, The Netherlands, March 10, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based...
March 06, 2008 08:00 ET | Source: Eurand N.V.

Eurand Reports Fourth Quarter and Year-end 2007 Key Achievements and Financial Results

Highlights: * Completed New Drug Application (NDA) submission for Zentase(tm) (EUR-1008); accepted by Food and Drug Administration (FDA) and granted priority review * Acquired the...
March 03, 2008 09:00 ET | Source: Eurand N.V.

Eurand CEO Gearoid Faherty Recognized by the Boomer Esiason Foundation

MILAN, Italy, March 3, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its...